Clinical trials
Completed Phase 1 Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
382 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 7 |
| 2002 | 8 |
| 2003 | 12 |
| 2004 | 11 |
| 2005 | 18 |
| 2006 | 16 |
| 2007 | 17 |
| 2008 | 23 |
| 2009 | 14 |
| 2010 | 17 |
| 2011 | 19 |
| 2012 | 28 |
| 2013 | 14 |
| 2014 | 26 |
| 2015 | 26 |
| 2016 | 15 |
| 2017 | 21 |
| 2018 | 13 |
| 2019 | 15 |
| 2020 | 10 |
| 2021 | 15 |
| 2022 | 7 |
| 2023 | 3 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 382 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 25 |
| Celgene | 18 |
| Memorial Sloan Kettering Cancer Center | 11 |
| Millennium Pharmaceuticals, Inc. | 10 |
| Novartis Pharmaceuticals | 10 |
| Merck Sharp & Dohme LLC | 9 |
| Mayo Clinic | 8 |
| Sanofi | 8 |
| Amgen | 7 |
| Janssen Pharmaceutical K.K. | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 382 |
| Lymphoma, Non-Hodgkin | 85 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 72 |
| Neoplasms, Plasma Cell | 70 |
| Hodgkin Disease | 68 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 65 |
| Lymphoma | 62 |
| Lymphoma, Large B-Cell, Diffuse | 62 |
| Leukemia, Myeloid, Acute | 60 |
| Lymphoma, Mantle-Cell | 56 |
Trials
Showing 1 to 25 of 382. Each trial links to its page on Pharma Observatory.
282 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.